4//SEC Filing
Patel Purav 4
Accession 0001437749-21-028321
CIK 0001742927other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:32 PM ET
Size
5.5 KB
Accession
0001437749-21-028321
Insider Transaction Report
Form 4
Patel Purav
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-08+5,300→ 5,300 totalExercise: $3.78Exp: 2031-12-07→ Common Stock, par value $0.001 per share (5,300 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.
Documents
Issuer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK 0001742927
Entity typeother
Related Parties
1- filerCIK 0001818246
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:32 PM ET
- Size
- 5.5 KB